Wu et al. showed that NEAT1 in blood had high sensitivity and specificity in distinguishing colorectal cancer patients from normal control patients, both of which were 83.3%, indicating that NEAT1 could provide an important basis for early screening of CRC [84]. The gene discussed is NEAT1; the disease is colorectal carcinoma.